Publications 2021

Solli KK, Opheim A, Latif ZEH, Krajci P, Benth JSA, Kunoe N, Tanum L (2021)
Adapting treatment length to opioid-dependent individuals' needs and preferences: a 2-year follow-up to a 1-year study of extended-release naltrexone
Addiction, 116 (8), 2084-2093
DOI 10.1111/add.15378

Publications 2019

Latif ZEH, Benth JS, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L (2019)
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone A Randomized Clinical Trial and Follow-up Study
JAMA Psychiatry, 76 (2), 127-134
DOI 10.1001/jamapsychiatry.2018.3537

Latif ZEH, Solli KK, Opheim A, Kunoe N, Benth JS, Krajci P, Sharma-Haase K, Tanum L (2019)
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study
Am. J. Addict., 28 (2), 77-85
DOI 10.1111/ajad.12859

Solli KK, Kunoe N, Latif ZEH, Sharma-Haase K, Opheim A, Krajci P, Gaulen Z, Benth JS, Tanum L (2019)
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial
Eur. Addict. Res., 25 (6), 303-309
DOI 10.1159/000501931

Publications 2018

Henriksen K, Jacobsen JA, Henriksen EM, Gomes L, Waal H, Krajci P (2018)
The LASSO Program in Oslo: Harm Reduction Using Buprenorphine-Naloxone (Suboxone (R)) in a Low Threshold Setting
Eur. Addict. Res., 24 (6), 286-292
DOI 10.1159/000495188

Solli KK, Latif ZEH, Opheim A, Krajci P, Sharma-Haase K, Benth JS, Tanum L, Kunoe N (2018)
Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trial
Addiction, 113 (10), 1840-1849
DOI 10.1111/add.14278

Publications 2017

Tanum L, Solli KK, Latif ZEH, Benth JS, Opheim A, Sharma-Haase K, Krajci P, Kunoe N (2017)
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence A Randomized Clinical Noninferiority Trial
JAMA Psychiatry, 74 (12), 1197-1205
DOI 10.1001/jamapsychiatry.2017.3206

Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D'Agnone O, Alho H, Rolland B (2017)
Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model
Eur. J. Gastroenterol. Hepatol., 29 (11), 1206-1214
DOI 10.1097/MEG.0000000000000962

Publications 2016

Henriksen K, Waal H, Krajci P (2016)
Will non-compliant 'hard-to-treat' opioid-dependent patients profit from low threshold methadone treatment? A prospective 15-month evaluation of patients on Low Dosage Methadone treatment at Oslo University Hospital
Heroin Addict. Relat. Clin. Probl., 18 (3), 23-27

Maremmani I, Rolland B, Somaini L, Roncero C, Reimer J, Wright N, Littlewood R, Krajci P, Alho H, D'Agnone O, Simon N (2016)
Buprenorphine dosing choices in specific populations: review of expert opinion
Expert Opin. Pharmacother., 17 (13), 1727-1731
DOI 10.1080/14656566.2016.1209486

Reimer J, Wright N, Somaini L, Roncero C, Maremmani I, McKeganey N, Littlewood R, Krajci P, Alho H, D'Agnone O (2016)
The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus
Eur. Addict. Res., 22 (2), 99-106
DOI 10.1159/000438988

Wright N, D'Agnone O, Krajci P, Littlewood R, Alho H, Reimer J, Roncero C, Somaini L, Maremmani I (2016)
Addressing misuse and diversion of opioid substitution medication: guidance based on systematic evidence review and real-world experience
J. Public Health, 38 (3), E368-E374
DOI 10.1093/pubmed/fdv150

Publications 2015

Alho H, D'Agnone O, Krajci P, McKeganey N, Maremmani I, Reimer J, Roncero C, Somaini L, Wright N, Littlewood R (2015)
The extent of misuse and diversion of medication for agonist opioid treatment: A review and expert opinions
Heroin Addict. Relat. Clin. Probl., 17 (2-3), 25-33

Alho H, Jansen J, Krajci P, Littlewood R, Runarsdottir V, Nyberg F (2015)
Misuse and diversion of agonist opioid treatment medicines: assessment of the scale of the problem and review of the changing environment for care in the Nordic countries
Heroin Addict. Relat. Clin. Probl., 17 (5), 43-49

Opdal MS, Arnesen M, Muller LD, Hullstein I, Sayed K, Brors O, Kringen M, Sagedal S, Gjesdal K, Krajci P (2015)
Effects of Hemodialysis on Methadone Pharmacokinetics and QTc
Clin. Ther., 37 (7), 1594-1599
DOI 10.1016/j.clinthera.2015.04.009

Publications 2005

Vermund H, Krajci P, Eide TJ, Winther F (2005)
Histopathological grading of laryngectomy specimens
APMIS, 113 (7-8), 473-488
DOI 10.1111/j.1600-0463.2005.apm_24.x

Publications 2004

Vermund H, Krajci P, Eide TJ, Winther F (2004)
Laryngectomy whole organ serial sections - Histological parameters correlated with recurrence rate
Acta Oncol., 43 (1), 98-107
DOI 10.1080/02841860310020366

Publications 1999

Johansen FE, Pekna M, Norderhaug IN, Haneberg B, Hietala MA, Krajci P, Betsholtz C, Brandtzaeg P (1999)
Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice
J. Exp. Med., 190 (7), 915-921
DOI 10.1084/jem.190.7.915

Nilsen EM, Johansen FE, Kvale D, Krajci P, Brandtzaeg P (1999)
Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes
Eur. J. Immunol., 29 (1), 168-179
DOI 10.1002/(SICI)1521-4141(199901)29:01<168::AID-IMMU168>3.0.CO;2-8

Norderhaug IN, Johansen FE, Krajci P, Brandtzaeg P (1999)
Domain deletions in the human polymeric Ig receptor disclose differences between its dimeric IgA and pentameric IgM interaction
Eur. J. Immunol., 29 (10), 3401-3409
DOI 10.1002/(SICI)1521-4141(199910)29:10<3401::AID-IMMU3401>3.0.CO;2-G

Publications 1998

Johansen FE, Bosloven BA, Krajci P, Brandtzaeg P (1998)
A composite DNA element in the promoter of the polymeric immunoglobulin receptor regulates its constitutive expression
Eur. J. Immunol., 28 (4), 1161-1171
DOI 10.1002/(SICI)1521-4141(199804)28:04<1161::AID-IMMU1161>3.0.CO;2-S

Publications 1997

Winberg JO, HammamiHauasli N, Nilssen O, AntonLamprecht I, Naylor SL, Kerbacher K, Zimmermann M, Krajci P, GeddeDahl T, BrucknerTuderman L (1997)
Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene
Hum. Mol. Genet., 6 (7), 1125-1135
DOI 10.1093/hmg/6.7.1125

Publications 1996

Krajci P, Meling GI, Andersen SN, Hofstad B, Vatn MH, Rognum TO, Brandtzaeg P (1996)
Secretory component mRNA and protein expression in colorectal adenomas and carcinomas
Br. J. Cancer, 73 (12), 1503-1510
DOI 10.1038/bjc.1996.284

Publications 1995

Brandtzaeg P, Krajci P (1995)
The enterocyte and immunoglobulin transport
Dyn.Nutr.Res., 4, 1-17

KRAJCI P, KVALE D, BRANDTZAEG P (1995)
Cloning, chromosomal localization, and linkage analysis of the gene encoding human transmembrane secretory component (the poly-Ig receptor)
Adv.Exp.Med.Biol., 371, 617-623

KULSETH MA, KRAJCI P, MYKLEBOST O, ROGNE S (1995)
CLONING AND CHARACTERIZATION OF 2 FORMS OF BOVINE POLYMERIC IMMUNOGLOBULIN RECEPTOR CDNA
DNA Cell Biol., 14 (3), 251-256
DOI 10.1089/dna.1995.14.251

NILSEN EM, LUNDIN KEA, KRAJCI P, SCOTT H, SOLLID LM, BRANDTZAEG P (1995)
GLUTEN SPECIFIC, HLA-DQ RESTRICTED T-CELLS FROM CELIAC MUCOSA PRODUCE CYTOKINES WITH THL OR THO PROFILE DOMINATED BY INTERFERON-GAMMA
Gut, 37 (6), 766-776
DOI 10.1136/gut.37.6.766

NORSTEIN J, KRAJCI P, BERGAN A, GEIRAN O (1995)
INTESTINAL PERFORATION AFTER INGESTION OF A BLISTER-WRAPPED TABLET
Lancet, 346 (8985), 1308
DOI 10.1016/S0140-6736(95)91918-X

Publications 1993

KRAJCI P, TASKEN K, KVALE D, BRANDTZAEG P (1993)
INTERFERON-GAMMA STIMULATION OF MESSENGER-RNA FOR HUMAN SECRETORY COMPONENT (POLY-IG RECEPTOR) DEPENDS ON CONTINUOUS INTERMEDIATE PROTEIN-SYNTHESIS
Scand. J. Immunol., 37 (2), 251-256
DOI 10.1111/j.1365-3083.1993.tb01763.x

Publications 1992

BRANDTZAEG P, HALSTENSEN TS, HUITFELDT HS, KRAJCI P, KVALE D, SCOTT H, THRANE PS (1992)
EPITHELIAL EXPRESSION OF HLA, SECRETORY COMPONENT (POLY-IG RECEPTOR), AND ADHESION MOLECULES IN THE HUMAN ALIMENTARY-TRACT
Ann.NY Acad.Sci., 664, 157-179
DOI 10.1111/j.1749-6632.1992.tb39758.x

Krajči P (1992)
Molecular biology of human secretory component (the poly-Ig receptor: characterization of cDNA and genomic clones, chromosomal assignment, and mRNA expression
Laboratory for Immunohistochemistry and Immunopathology (LIIPAT), Institute of Pathology, University of Oslo, The National Hospital, Rikshospitalet, Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 930575830, ISBN 82-7633-017-7

KRAJCI P, GEDDEDAHL T, HOYHEIM B, ROGDE S, OLAISEN B, BRANDTZAEG P (1992)
THE GENE ENCODING HUMAN TRANSMEMBRANE SECRETORY COMPONENT (LOCUS PIGR) IS LINKED TO D1S58 ON CHROMOSOME-1
Hum. Genet., 90 (3), 215-219
DOI 10.1007/BF00220065

KRAJCI P, KVALE D, TASKEN K, BRANDTZAEG P (1992)
MOLECULAR-CLONING AND EXON-INTRON MAPPING OF THE GENE ENCODING HUMAN TRANSMEMBRANE SECRETORY COMPONENT (THE POLY-IG RECEPTOR)
Eur. J. Immunol., 22 (9), 2309-2315
DOI 10.1002/eji.1830220920

KVALE D, KRAJCI P, BRANDTZAEG P (1992)
EXPRESSION AND REGULATION OF ADHESION MOLECULES ICAM-1 (CD54) AND LFA-3 (CD58) IN HUMAN INTESTINAL EPITHELIAL-CELL LINES
Scand. J. Immunol., 35 (6), 669-676
DOI 10.1111/j.1365-3083.1992.tb02973.x

SOLBERG R, SISTONEN P, TRASKELIN AL, BERUBE D, SIMARD J, KRAJCI P, JAHNSEN T, DELACHAPELLE A (1992)
MAPPING OF THE REGULATORY SUBUNITS RI-BETA AND RII-BETA OF CAMP-DEPENDENT PROTEIN-KINASE GENES ON HUMAN CHROMOSOME-7
Genomics, 14 (1), 63-69
DOI 10.1016/S0888-7543(05)80284-8

Publications 1991

KRAJCI P, GRZESCHIK KH, VANKESSEL AHMG, OLAISEN B, BRANDTZAEG P (1991)
THE HUMAN TRANSMEMBRANE SECRETORY COMPONENT (POLY-IG RECEPTOR) - MOLECULAR-CLONING, RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM AND CHROMOSOMAL SUBLOCALIZATION
Hum. Genet., 87 (6), 642-648
DOI 10.1007/BF00201717

Publications 1989

BRANDTZAEG P, HALSTENSEN TS, KETT K, KRAJCI P, KVALE D, ROGNUM TO, SCOTT H, SOLLID LM (1989)
IMMUNOBIOLOGY AND IMMUNOPATHOLOGY OF HUMAN GUT MUCOSA - HUMORAL IMMUNITY AND INTRAEPITHELIAL LYMPHOCYTES
Gastroenterology, 97 (6), 1562-1584
DOI 10.1016/0016-5085(89)90406-X

KRAJCI P, SOLBERG R, SANDBERG M, OYEN O, JAHNSEN T, BRANDTZAEG P (1989)
MOLECULAR-CLONING OF THE HUMAN TRANSMEMBRANE SECRETORY COMPONENT (POLY-IG RECEPTOR) AND ITS MESSENGER-RNA EXPRESSION IN HUMAN-TISSUES
Biochem. Biophys. Res. Commun., 158 (3), 783-789
DOI 10.1016/0006-291X(89)92790-3

Publications 1986

IVERSEN OH, KRAJCI P, THORESEN G (1986)
THE FATE OF EPIDERMAL COLCEMID-ARRESTED MITOSES
Virchows Arch. B-Cell Molec. Pathol., 51 (2), 115-126
DOI 10.1007/BF02899022

Publications 1980

Krajči P, Thoresen G (1980)
Veneriske sykdommer og samfunnsendringer: "sammenhengen mellom veneriske sykdommer og strukturelle endringer i samfunnsforhold i Norge i perioden 1860 til 1900"
In Spesialoppgave, Universitetet i Oslo, Oslo, 36 s.
BIBSYS 051913356